✦ LIBER ✦

Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)

✍ Scribed by O'Rourke, M.; Garfield, D.; Ellis, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

An open phase II trial of gemcitabine, o

✍ Trédaniel, J.; Becht, C.; Bekradda, M.; De Cremoux, H.; Alexandre, J.; Chomy, F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Results of a phase II multicenter trial

✍ Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase II study of weekly paclitaxel as s

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Phase II trial of the multi-targeted ant

✍ Rusthoven, J.; Eisenhauer, E.; Butts, C.; Gregg, R.; Dancey, J.; Fisher, B.; Igl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 261 KB

227 Paclitaxel, carboplatin and mitomyci

✍ Zarogoulidis, K.; Papagiannis, A.; Constantinidis, T.C.; Vogiatzis, A.K.; Pella, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB